| 000 | 01716 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513160050.0 | ||
| 264 | 0 | _c19990301 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0891-6640 | ||
| 024 | 7 |
_a10.1111/j.1939-1676.1998.tb02151.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZemann, B I | |
| 245 | 0 | 0 |
_aA combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. _h[electronic resource] |
| 260 |
_bJournal of veterinary internal medicine _c |
||
| 300 |
_a465-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDog Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasm Staging _xveterinary |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aMoore, A S | |
| 700 | 1 | _aRand, W M | |
| 700 | 1 | _aMason, G | |
| 700 | 1 | _aRuslander, D M | |
| 700 | 1 | _aFrimberger, A E | |
| 700 | 1 | _aWood, C A | |
| 700 | 1 | _aL'Heureux, D A | |
| 700 | 1 | _aGliatto, J | |
| 700 | 1 | _aCotter, S M | |
| 773 | 0 |
_tJournal of veterinary internal medicine _gvol. 12 _gno. 6 _gp. 465-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1939-1676.1998.tb02151.x _zAvailable from publisher's website |
| 999 |
_c9820422 _d9820422 |
||